benzocaine 0.2 MG/MG Oral Gel [Anbesol]

RxCUI
1052633
RxNorm name
benzocaine 0.2 MG/MG Oral Gel [Anbesol]
Display name
ANBESOL (Oral Gel)
Full name
benzocaine 0.2 MG/MG Oral Gel [Anbesol]
Term type
SBD
Status
Active
Strength
20%
Dose form
Gel
Route
Oral Gel
Updated
2026-06-05 07:08:15

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Gel346169

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRAnbesol 0.2 MG/MG Oral GelNAMES
RxNorm Namebenzocaine 0.2 MG/MG Oral Gel [Anbesol]NAMES
RxNorm SynonymAnbesol 0.2 MG/MG Oral GelNAMES
RxNorm SynonymAnbesol Maximum Strength 20 % Mucous Membrane GelNAMES
TTYSBDATTRIBUTES
SPL_SET_IDdcc37403-0192-4658-bb7a-059273ce0047CODES
RxCUI1052633CODES
MMSL_CODEBD14703CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
80070-220-3380070-220Anbesol BENZOCAINEFoundation Consumer BrandsM022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02280070-220Anbesol BENZOCAINEOTC MONOGRAPH DRUGFoundation Consumer Brands

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00573022525rxnav_ndcsyes
00573022567rxnav_ndcsyes
50024043203rxnav_ndcsyes
80070022033rxnav_ndcsyes
00573022501rxnav_historical
00573022510rxnav_historical
00573024625rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Anbesol Maximum StrengthBENZOCAINEFoundation Consumer Brandsdcc37403-0192-4658-bb7a-059273ce00472026-06-22WarningsExact identifier
ndc (package): 80070-220-33
ndc (product): 80070-220
ndc11 (package): 80070022033
rxcui: 1052633

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
dcc37403-0192-4658-bb7a-059273ce0047Anbesol Maximum Strength 20 % Oral GelPSN4Anbesol ® Maximum Strength20250219
dcc37403-0192-4658-bb7a-059273ce0047benzocaine 0.2 MG/MG Oral Gel [Anbesol]SBD4Anbesol ® Maximum Strength20250219
dcc37403-0192-4658-bb7a-059273ce0047Anbesol Maximum Strength 20 % Mucous Membrane GelSY4Anbesol ® Maximum Strength20250219
dcc37403-0192-4658-bb7a-059273ce0047Anbesol 0.2 MG/MG Oral GelSY4Anbesol ® Maximum Strength20250219

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
dcc37403-0192-4658-bb7a-059273ce0047Anbesol ® Maximum StrengthFoundation Consumer Brands20260622
dcc37403-0192-4658-bb7a-059273ce0047Anbesol ® Maximum StrengthFoundation Consumer Brands20250219
924a4421-cd8b-8e5c-d7e6-d022fabb694fDrug FactsGlaxoSmithKline Consumer Healthcare Holdings (US) LLC20220105
25bcfa70-64f9-18d6-51b0-83282c2f84beDrug FactsGlaxoSmithKline Consumer Healthcare Holdings (US) LLC20201125
b040a389-cb3d-4510-b81a-1ea41ce69139National Council for Prescription Drug Programs20120724
b7119f84-1b88-4cb3-aa5b-59c9b4548ee4National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD14703
CODESRxCUI1052633
CODESSPL_SET_IDdcc37403-0192-4658-bb7a-059273ce0047
NAMESPrescribable SynonymAnbesol Maximum Strength 20 % Oral Gel
NAMESRXNAV_STRAnbesol 0.2 MG/MG Oral Gel
NAMESRxNorm Namebenzocaine 0.2 MG/MG Oral Gel [Anbesol]
NAMESRxNorm SynonymAnbesol 0.2 MG/MG Oral Gel
NAMESRxNorm SynonymAnbesol Maximum Strength 20 % Mucous Membrane Gel
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon